Arrhythmia induction in the EP lab. ([2019])

• Record Type: Book
• Further Information: Note: Editor, Gabriel Cismaru.
• Editors: Cismaru, Gabriel
• Contents: Intro; Preface; Contents; About the Author; 1: Introduction: Why Do We Need Arrhythmia Induction?; 1.1 Better Outcome of Catheter Ablation When Clinical Arrhythmia Is Inducible; 1.2 Catheter Ablation of Accessory Pathways During ORT and AVNRT; 1.3 Activation Mapping in Patients with Premature Ventricular Contractions; 1.4 Activation Mapping in Patients with Ventricular Tachycardia; 1.5 Reproducibility of Symptoms During Electrophysiological Testing; References; 2: How to Induce Arrhythmias by Atrial and Ventricular Programmed Stimulation?; 2.1 Introduction; 2.2 Atrial Stimulation 2.3 Ventricular StimulationReferences; 3: How to Induce Arrhythmias with Isoprenaline; 3.1 Introduction; 3.2 Mechanism of Action; 3.2.1 Chemical Structure; 3.3 Pharmacology of Isoprenaline; 3.4 Doses of Isoprenaline; 3.4.1 Infusion Preparation (Tables 3.1 and 3.2); 3.5 Isoprenaline's Side Effects; 3.6 Animal Studies; 3.7 Human Studies; 3.7.1 Reversal of Encainide by Isoprenaline Infusion in Patients with Ventricular Tachycardia; 3.7.2 Reversal of Flecainide by Isoprenaline Infusion in Patients with Accessory Pathways 3.7.3 Reversal of Quinidine by Isoprenaline Infusion in Patients with Ventricular Tachycardia3.7.4 Reversal of Procainamide by Isoprenaline Infusion in Patients with Ventricular Tachycardia; 3.7.5 Reversal of Propafenone with Isoprenaline Infusion in Patients with Accessory Pathways; References; 4: How to Induce Arrhythmias with Orciprenaline; 4.1 Introduction; 4.2 Pharmacology; 4.3 Mechanism of Action; 4.4 Doses of Orciprenaline; 4.5 Preparation; 4.6 Side Effects of Orciprenaline; 4.7 Electrophysiological Effects of Orciprenaline; 4.7.1 Animal Studies; 4.7.2 Human Studies 4.7.2.1 Orciprenaline for Supraventricular Extrabeats Induction Due to 1:2 Atrioventricular Conduction4.7.2.2 Orciprenaline for AVNRT Induction; 4.7.2.3 Orciprenaline for PVC Induction; 4.7.2.4 Orciprenaline for AF Induction; 4.7.2.5 Orciprenaline for VT Induction; References; 5: How to Induce Arrhythmias with Adrenaline; 5.1 Introduction; 5.1.1 Chemical Structure; 5.2 Pharmacology of Adrenaline; 5.3 Mechanism of Action; 5.4 Doses of Adrenaline; 5.5 Contraindications to Adrenaline; 5.6 Side Effects of Adrenaline; 5.7 Animal Studies; 5.8 Human Studies 5.8.1 Inhibition of Verapamil Effects by Adrenaline Infusion in Patients with PSVT5.8.2 Inhibition of Quinidine Effects by Adrenaline Infusion in Patients with VT; 5.8.3 Inhibition of Amiodarone Effects by Adrenaline Infusion in Patients with VT; 5.8.4 Inhibition of Quinidine Effects by Adrenaline Infusion in Patients with WPW Syndrome; References; 6: How to Induce Arrhythmias with Atropine; 6.1 Introduction; 6.2 Mechanism of Action; 6.3 Pharmacokinetics; 6.4 Doses of Atropine; 6.5 Preparation; 6.6 Contraindications to Atropine; 6.7 Side Effects of Atropine
• Publisher Details: Cham : Springer
• Publication Date: 2019
• Copyright Date: 2019
• Extent: 1 online resource, illustrations (some color)
• Subjects: 616.1/28; Arrhythmia -- Diagnosis; Invasive electrophysiologic testing; HEALTH & FITNESS / Diseases / General; MEDICAL / Clinical Medicine; MEDICAL / Diseases; MEDICAL / Evidence-Based Medicine; MEDICAL / Internal Medicine; Electronic books
• Languages: English
• ISBNs: 9783319927299; 3319927299
• Related ISBNs: 9783319927282
• Notes: Note: Includes bibliographical references.; Note: Online resource ; title from PDF title page (EBSCO, viewed January 10, 2019).
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.